When Mary C. Moran and her colleagues at the U.S. Centers for Disease Control and Prevention set out to understand why some American children weren't getting their rotavirus vaccine, they uncovered a surprisingly stark picture: timing, poverty, and prematurity are conspiring to leave thousands of infants vulnerable to a preventable illness.

Rotavirus causes severe diarrheal disease in young children, and the vaccine's first dose must be given by 14 weeks and six days of age—a strict window that shapes everything about how and where children get protected. Moran's study, published in Pediatrics and drawing on data from nearly 25,000 children born from 2007 onward through the New Vaccine Surveillance Network, identified the specific barriers that derail vaccination for the most vulnerable.

The findings are sobering. Children born extremely prematurely faced 14.6 times greater odds of not initiating the rotavirus vaccine series compared to their full-term peers. This is not incidental: more than half of extremely preterm infants in neonatal intensive care units stayed hospitalized until they were 15 weeks old or older—past the vaccination deadline. Even more striking, children without health insurance were 2.2 times less likely to receive the vaccine than insured children. The researchers also found that receiving the diphtheria, tetanus, and pertussis vaccine at 15 weeks or older showed a startlingly high odds ratio of 30.0, suggesting that delayed vaccination cascades create missed opportunities across the board.

The current guidelines prohibit administering rotavirus vaccine in the NICU, which Moran and her team argue creates an unnecessary barrier for the children who need protection most. "The strict upper age limit and recommendation against administering RVV in the NICU create additional barriers to receiving RVV," the authors wrote. "Re-evaluating guidelines around administering RVV in the NICU may help reduce the number of children who miss the opportunity to be vaccinated and potentially benefit from these vaccines."

What makes this research particularly urgent is the disparity embedded in these numbers. A child born prematurely to an uninsured family faces a compounding set of obstacles—longer hospital stays that extend past the vaccination window, less reliable access to outpatient care, and fewer touchpoints with the healthcare system. Meanwhile, children born shortly after rotavirus vaccine introduction in 2007 to 2009 were 3.3 times more likely to miss vaccination, possibly reflecting early confusion about the new recommendation.

The study suggests a straightforward path forward: changing NICU protocols to allow rotavirus vaccination in intensive care settings could eliminate one major barrier entirely. For extremely preterm infants who will be hospitalized during the critical window, vaccinating them before discharge would ensure they're protected without requiring parents to remember an additional appointment or navigate barriers like lack of insurance coverage.

Public health officials now have concrete evidence that the current system isn't working for everyone. The solution lies not in changing the vaccine itself—which is safe and effective—but in changing where and when it's administered to match the reality of how premature infants move through the healthcare system. For thousands of families, that distinction could mean the difference between protection and vulnerability.